MK-1439

Description	Doravirine demonstrated robust antiviral activity and good tolerability in a small clinical study of 7-day monotherapy reported at the 20th Conference on Retroviruses and Opportunistic Infections . Doravirine appeared safe and generally well tolerated with most adverse events being mild-to-moderate.
Pathways	Microbiology/Virology
Targets	HIV

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.